Psilocybin therapy for hopelessness in advanced cancer
Part of Cancer clinical trials.
This study tests whether a drug called psilocybin, combined with supportive talk therapy, can help reduce feelings of hopelessness and loss of meaning in people with advanced cancer. If it works, it could offer a new way to improve emotional well-being during a difficult time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have advanced cancer (stage III, IV, or metastatic) or stage II that is not responding to treatment.
- You experience significant demoralization or loss of meaning (assessed by a questionnaire).
- You are expected to live at least 6 more months.
- You can attend about 4-5 therapy sessions over 6-8 weeks, including a full-day dosing session.
- You have someone to accompany you for 12 hours after the dosing session.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a medicine called psilocybin, given with talk therapy, can safely help people with advanced cancer who feel very demoralized. Demoralization is a deep sense of hopelessness or loss of meaning. The goal is to see if this treatment can improve your emotional well-being.
This trial tests whether a drug called psilocybin, given with therapy, can help people with advanced cancer who are feeling anxious or depressed. You must have a stable cancer and be willing to travel to Houston for treatment.
This study tests whether a therapy combining psilocybin (a psychedelic substance) with counseling can help improve emotional well-being in people with advanced cancer who have symptoms of depression. It aims to see if this approach can ease suffering and improve quality of life.
This trial studies whether psilocybin (with support and therapy) can reduce anxiety in people with advanced cancer. It may help with distress and quality of life, while the study team monitors safety closely.
This trial tests whether very low doses of psilocybin (a psychedelic substance) can help reduce emotional distress in people with a life-limiting illness. If you are receiving palliative care and feeling anxious or depressed, this study might offer a way to explore a new treatment option.
This Phase 2 study tests whether psilocybin therapy can reduce deep distress (“demoralization”) in people receiving palliative (comfort-focused) care. It may help with mood and well-being, but you must meet safety and medication requirements to join.
Hear when a new Advanced Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.